3,3-Difluoropropan-1-amine Hydrochloride - CAS 1010097-89-8
Catalog: |
BB055806 |
Product Name: |
3,3-Difluoropropan-1-amine Hydrochloride |
CAS: |
1010097-89-8 |
Synonyms: |
3,3-Difluoro-1-aminopropane Hydrochloride; 3,3-Difluoropropan-1-amine Monohydrochloride; 3,3-Difluoropropylamine Hydrochloride |
IUPAC Name: | 3,3-difluoropropan-1-aminehydrochloride |
Description: | 3,3-Difluoropropan-1-amine Hydrochloride can be useful in the preparation of hydroxamate- based histone deacetylase inhibitors. |
Molecular Weight: | 95.09 + 36.46 |
Molecular Formula: | C3H7F2N·HCl |
Canonical SMILES: | C(CN)C(F)F.Cl |
InChI: | InChI=1S/C3H7F2N.ClH/c4-3(5)1-2-6/h3H,1-2,6H21H |
InChI Key: | GZIRVKYLTVWXDL-UHFFFAOYSA-N |
References: | Shultz, M. D., et al. J. Med. Chem., 54, 4752 (2011). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021225912-A1 | Treatment of respiratory diseases with amino acid compounds | 20200507 |
WO-2021121327-A1 | Substituted straight chain spiro derivatives | 20191219 |
WO-2021053344-A1 | New compounds | 20190920 |
US-2020352942-A1 | Dosage forms and regimens for amino acid compounds | 20190408 |
US-10851073-B2 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
US-2020299246-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
WO-2020186199-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
AU-2020234712-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
CA-3131894-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
CN-114025844-A | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20190314 |
Complexity: | 30 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 131.0313333 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 131.0313333 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 26Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[1427004-19-0]
DBCO-PEG4-NHS ester
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[1643-20-5]
N,N-dimethyldodecan-1-amine oxide
-
[31295-50-8]
N'-[2-[2-(2-piperazin-1-ylethylamino)ethylamino]ethyl]ethane-1,2-diamine
-
[94086-78-9]
Isopropyl 4-[4-[N,N-bis(2-hydroxyethyl)amino]phenyl]butyrate
-
[1082828-31-6]
Ethyl 5-bromo-1-(4-fluorophenyl)-1H-pyrazole-4-carboxylate
INDUSTRY LEADERS TRUST OUR PRODUCTS